161 related articles for article (PubMed ID: 35901623)
1. Effect of Pap-smear and sociodemographic factors on cervical cancer risk in Estonia: A population-based case-control study.
Nõmm O; Veerus P; Orumaa M; Innos K
Cancer Epidemiol; 2022 Oct; 80():102231. PubMed ID: 35901623
[TBL] [Abstract][Full Text] [Related]
2. Inequalities in reported use of cervical screening in Estonia: results from cross-sectional studies in 2004-2020.
Suurna M; Orumaa M; Ringmets I; Pärna K
BMC Womens Health; 2022 Dec; 22(1):545. PubMed ID: 36566176
[TBL] [Abstract][Full Text] [Related]
3. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
Nygård JF; Skare GB; Thoresen SØ
J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
[TBL] [Abstract][Full Text] [Related]
4. Impact of implementing a nationwide cervical cancer screening program on female population coverage by Pap-tests in Estonia.
Veerus P; Arbyn M; Amati C; Paolo B;
Tumori; 2010; 96(4):524-8. PubMed ID: 20968130
[TBL] [Abstract][Full Text] [Related]
5. Self-reported history of Pap-smear in HIV-positive women in Northern Italy: a cross-sectional study.
Dal Maso L; Franceschi S; Lise M; De' Bianchi PS; Polesel J; Ghinelli F; Falcini F; Finarelli AC;
BMC Cancer; 2010 Jun; 10():310. PubMed ID: 20565935
[TBL] [Abstract][Full Text] [Related]
6. Factors influencing the prevalence of cervical cancer screening in Malaysia: a nationwide survey.
Chan YM; Ismail MZH; Khaw WF
BMC Womens Health; 2023 Jul; 23(1):389. PubMed ID: 37491253
[TBL] [Abstract][Full Text] [Related]
7. CIN 2/3 and cervical cancer in an organised screening programme after an unsatisfactory or a normal Pap smear: a seven-year prospective study of the Norwegian population-based screening programme.
Nygård JF; Sauer T; Nygård M; Skare GB; Thoresen SØ
J Med Screen; 2004; 11(2):70-6. PubMed ID: 15153321
[TBL] [Abstract][Full Text] [Related]
8. Sociodemographic factors of Pap smear screening in Taiwan.
Wang PD; Lin RS
Public Health; 1996 Mar; 110(2):123-7. PubMed ID: 8901257
[TBL] [Abstract][Full Text] [Related]
9. Effect of an antepartum Pap smear on the coverage of a cervical cancer screening programme: a population-based prospective study.
Nygård M; Daltveit AK; Thoresen SO; Nygård JF
BMC Health Serv Res; 2007 Jan; 7():10. PubMed ID: 17244348
[TBL] [Abstract][Full Text] [Related]
10. A mobile unit: an effective service for cervical cancer screening among rural Thai women.
Swaddiwudhipong W; Chaovakiratipong C; Nguntra P; Mahasakpan P; Tatip Y; Boonmak C
Int J Epidemiol; 1999 Feb; 28(1):35-9. PubMed ID: 10195661
[TBL] [Abstract][Full Text] [Related]
11. Effect of a mobile unit on changes in knowledge and use of cervical cancer screening among rural Thai women.
Swaddiwudhipong W; Chaovakiratipong C; Nguntra P; Mahasakpan P; Lerdlukanavonge P; Koonchote S
Int J Epidemiol; 1995 Jun; 24(3):493-8. PubMed ID: 7672887
[TBL] [Abstract][Full Text] [Related]
12. High-grade cervical abnormalities and cervical cancer in women following a negative Pap smear with and without an endocervical component: a cohort study with 10 years of follow-up.
Sultana F; English DR; Simpson JA; Canfell K; Gertig DM; Saville M
Int J Cancer; 2014 Sep; 135(5):1213-9. PubMed ID: 24488882
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with advanced-stage diagnosis of cervical cancer in Estonia: a population-based study.
Šavrova A; Jaal J; Nõmm O; Innos K
Public Health; 2023 Dec; 225():369-375. PubMed ID: 37989009
[TBL] [Abstract][Full Text] [Related]
14. Organised vs. spontaneous Pap-smear screening for cervical cancer: A case-control study.
Nieminen P; Kallio M; Anttila A; Hakama M
Int J Cancer; 1999 Sep; 83(1):55-8. PubMed ID: 10449608
[TBL] [Abstract][Full Text] [Related]
15. Factors Affecting Non-Histologically Proven Invasive Cancer of the Uterine Cervix that Had an Abnormal Pap Smear: Results of the CCS Program.
Thipsanthiah K; Kamsa-Ard S; Musika W; Teemuangsai W; Hawlader MDH
Asian Pac J Cancer Prev; 2023 Oct; 24(10):3429-3436. PubMed ID: 37898847
[TBL] [Abstract][Full Text] [Related]
16. An audit of 1632 routinely collected cervical cancer screening smears from 398 women in Germany: Results from the TeQaZ Study.
Tanaka LF; Schoffer O; Schriefer D; Schauberger G; Ikenberg H; Klug SJ
Eur J Cancer; 2024 Apr; 201():113915. PubMed ID: 38364626
[TBL] [Abstract][Full Text] [Related]
17. Determinants and levels of cervical Cancer screening uptake among women of reproductive age in South Africa: evidence from South Africa Demographic and health survey data, 2016.
Akokuwebe ME; Idemudia ES; Lekulo AM; Motlogeloa OW
BMC Public Health; 2021 Nov; 21(1):2013. PubMed ID: 34740352
[TBL] [Abstract][Full Text] [Related]
18. Limited Pap screening associated with reduced risk of cervical cancer in South Africa.
Hoffman M; Cooper D; Carrara H; Rosenberg L; Kelly J; Stander I; Williamson AL; Denny L; du Toit G; Shapiro S
Int J Epidemiol; 2003 Aug; 32(4):573-7. PubMed ID: 12913031
[TBL] [Abstract][Full Text] [Related]
19. Cervical neoplasia in pap smears: risk of cervical intra-epithelial neoplasia (CIN) after negative or no prior smears in a population without a mass screening programme.
Forsmo S; Jacobsen BK; Stalsberg H
Int J Epidemiol; 1996 Feb; 25(1):53-8. PubMed ID: 8666505
[TBL] [Abstract][Full Text] [Related]
20. Women's knowledge about cervical cancer risk factors, screening, and reasons for non-participation in cervical cancer screening programme in Estonia.
Kivistik A; Lang K; Baili P; Anttila A; Veerus P
BMC Womens Health; 2011 Sep; 11():43. PubMed ID: 21951661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
